Search Within

Biostatistics Service

  1. "Gunjan Shah"
Formats
  1. Meeting Abstract (166)
  2. Journal Article (78)
  3. Research Letter (9)
  4. Correspondence (3)
Groups
  1. Bone Marrow Transplant (256)
  2. Center for Hematologic Malignancies (256)
  3. Department of Medicine (256)
  4. Epidemiology and Biostatistics (256)
  5. Hematologic Malignancies, Division of (256)
  6. Survivorship Research (256)

More Groups

People
  1. Gunjan Shah (256)
  2. Sergio Giralt (206)
  3. Michael Scordo (200)
  4. Sean Devlin (188)
  5. Miguel-Angel Perales (145)
  6. Parastoo Dahi (114)

More People

Years
  1. 2025 (20)
  2. 2024 (38)
  3. 2023 (48)
  4. 2022 (31)
  5. 2021 (19)
  6. 2020 (33)

More Years

Publications
  1. Blood (81)
  2. Biology of Blood and Marrow Transplantation (43)
  3. Clinical Lymphoma, Myeloma and Leukemia (24)
  4. Bone Marrow Transplantation (17)
  5. Blood Advances (16)
  6. Transplantation and Cellular Therapy (13)

More Publications

Publishers
  1. American Society of Hematology (97)
  2. Elsevier Inc. (84)
  3. Nature Publishing Group (28)
  4. American Society of Clinical Oncology (10)
  5. Taylor & Francis Group (7)
  6. American Association for Cancer Research (5)

More Publishers

Results (256)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PET-based biomarkers for toxicity prediction in CAR T-cell therapy for aggressive lymphoma: Evidence from a large-scale retrospective analysis
    Meeting Abstract

    Ucpinar, B. A.; Brown, S.; Bedmutha, A.; Leithner, D.; Raj, S.; Devlin, S.; Shah, G.; Perales, M. A.; Shouval, R.; Schoder, H.
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma
    Journal Article

    Adegbite, B.; Tan, C. R.; Shekarkhand, T.; Firestone, R. S.; Jurgens, E. M.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; Rajeeve, S.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costs
    Journal Article

    Burton, H.; Boussi, L.; Nemirovsky, D.; Derkach, A.; Ciervo, J.; Famulare, C.; Chin, K. K.; Valtis, Y.; Yisraeli Salman, M.; Patel, K.; more...
    Cancer (2025)

    Fulltext@MSK | Save
  • Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: A real-world experience
    Journal Article

    Hultcrantz, M.; Derkach, A.; Hassoun, H.; Korde, N.; MacLachlan, K.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C. R.; Chung, D. J.; more...
    Blood Neoplasia (2025)

    Fulltext@MSK | Save
  • Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma
    Correspondence

    Sebastian, T.; Rajeeve, S.; Farzana, T.; Firestone, R.; Jurgens, E.; Miller, K.; Costa, B.; Lesokhin, A.; Tan, C.; Shah, G.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • T-ICAHT: Grading and prognostic impact of thrombocytopenia after CAR T-cell therapy
    Journal Article

    Rejeski, K.; Sanz, J.; Fei, T.; Nair, M. S.; Hashmi, H.; Avigdor, A.; Beyar-Katz, O.; Bücklein, V. L.; Curran, K. J.; Einarsdottir, S.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Results from first-in-human phase I study of a novel CD19-1XX chimeric antigen receptor with calibrated signaling in Large B-cell lymphoma
    Journal Article

    Park, J. H.; Palomba, M. L.; Perica, K.; Devlin, S. M.; Shah, G.; Dahi, P. B.; Lin, R. J.; Salles, G.; Scordo, M.; Nath, K.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experience
    Journal Article

    Cassanello, G.; Luttwak, E.; Brown, S.; Devlin, S. M.; Imber, B.; Ip, A.; Leslie, L. A.; Accav, N. G.; Avigdor, A.; Marcus, R.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies
    Journal Article

    Einarsdottir, S.; Lobaugh, S.; Luan, D.; Gomez-Llobell, M.; Subramanian, P.; Devlin, S.; Chung, D.; Dahi, P. B.; Falchi, L.; Giralt, S.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Restarting teclistamab and talquetamab after prolonged dose delay may not require re–step-up dosing
    Research Letter

    Tan, C. R.; Wang, A.; Nemirovsky, D.; Derkach, A.; Shekarkhand, T.; Hamadeh, I.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save